The most frequently (≥10%) observed any grade adverse reactions in patients receiving rucaparib monotherapy were nausea, fatigue, dysgeusia, anemia, constipation, alanine aminotransferase (ALT) or aspartate aminotransferase (AST), diarrhea, abdominal pain, thrombocytopenia, decreased appetite neutropenia, headache, photosensitivity reactions, cough, dizziness, arthralgia, increase in blood creatinine concentration, dyspepsia [76]. The gene discussed is GPT; the disease is anemia (phenotype).